Xeris Biopharma Holdings Inc (XERS)
3.475
+0.06
(+1.61%)
USD |
NASDAQ |
Dec 24, 13:00
3.40
-0.08
(-2.16%)
After-Hours: 13:59
Xeris Biopharma Holdings Total Liabilities (Quarterly): 349.43M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 121.78M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.10M |
| Shareholders Equity (Quarterly) | -28.32M |
| Debt to Equity Ratio | -8.166 |
| Current Ratio | 1.789 |
| Net Debt Paydown Yield | -2.03% |